Syndromic testing, patient, girl
October 5

World Meningitis Awareness Day – Knowledge Hub

Start your learning path

When you can detect more, you can do more

Every day, meningitis changes lives – and claims them. Every hour without the right diagnosis lowers the chances of recovery.

But with the right tools, you can change the trajectory of meningitis and encephalitis care. Early, broad pathogen testing with syndromic panels has been shown to:

This World Meningitis Day, take a few minutes to learn how syndromic testing can make a difference for your patients. And why more clinicians trust the QIAstat-Dx Meningitis/Encephalitis (ME) Panel – now with CMV detection – to make faster, more confident decisions.

Explore our knowledge hub: Stream clinical updates on S. pyogenes, an emerging CNS pathogen all clinicians should be aware of. Read concise CNS infection case studies, and download our in-depth ebook to dive deeper when you have time. Choose the path that fits your day – or explore them all to get the full picture.

Start your learning path
–
The clinical impact of syndromic testing for meningoencephalitis
New: QIAstat-Dx sets the benchmark for meningitis testing

The WHO now strongly recommends PCR-based testing for fast pathogen detection in patients with suspected CNS infections (5).

Our new IVDR-compliant QIAstat-Dx ME Panel aligns with the latest WHO guidelines and offers added value with unique detection of emerging pathogens like S. pyogenes. With some of the broadest coverage available – 16 clinically relevant pathogens, including CMV – it helps you detect more causes at once and get answers in about an hour.

Get the clarity you need to make confident decisions.

Learn more
QIAstat, QIAstat-Dx, ME, meningitis, encephalitis, meningitis/encephalitis, panel, cartridge
Monthly distribution of invasive Group A Streptococcal (iGAS) disease in children in Spain between 2019 and 2022 (1)
Streptococcus pyogenes - illustration for sticker
Positive detections in 2023 using QIAstat-Dx ME Panel (3)
S. pyogenes can't hide from QIAstat‑Dx

For infectious diseases, early detection is critical. But many routine tests can miss crucial pathogens. QIAstat-Dx is built to catch the pathogens others may overlook, including S. pyogenes in CNS infections. Find out what makes QIAstat-Dx unique and learn why this matters for your patients.

Discover the difference
References
  1. Crook J, Xu M, Slaughter JC, et al. Impact of clinical guidance and rapid molecular pathogen detection on evaluation and outcomes of febrile or hypothermic infants. Infect Control Hosp Epidemiol. 2020;41(11):1285–1291. doi:10.1017/ice.2020.317
  2. Clarke, K., Collins, M., Khakh, M., & Hardy, K. (2023, November). P103: Rapid diagnostics to improve the management of meningitis and encephalitis. Poster session presented at the Federation of Infection Societies Conference, Edinburgh, UK.
  3. McDonald D, Gagliardo C, Chiu S, Di Pentima MC. Antibiotics (Basel). 2020;9(11):822. doi:10.3390/antibiotics9110822
  4. Hueth, K.D.; Thompson-Leduc, P.; Totev, T.I.; Milbers, K.; Timbrook, T.T.; Kirson, N.; Hasbun, R. Assessment of the Impact of a Meningitis/Encephalitis Panel on Hospital Length of Stay: A Systematic Review and Meta-Analysis. Antibiotics 2022, 11, 1028. https://doi.org/10.3390/antibiotics11081028
  5. World Health Organization. Guidelines for the Diagnosis, Treatment and Prevention of Meningitis. Geneva: World Health Organization; 2025. Accessed June 27, 2025. https://www.who.int/publications/i/item/9789240108042 

In some cases, data cited pertains to the use of a device from another manufacturer.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).